SE514908C2 - Medel för benrekonstruktion - Google Patents

Medel för benrekonstruktion

Info

Publication number: SE514908C2
Authority: SE; Sweden
Prior art keywords: bone; calcium phosphate; agent according; lipid; granules
Prior art date: 1998-07-13

Application number

SE9802529A

Other languages

English (en)

Swedish (sv)

Other versions

SE9802529L (sv

SE9802529D0 (sv

Inventor

Cecilia Larsson

Helena Ljusberg-Wahren

Original Assignee

Gs Dev Ab

Nobel Biocare Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-13

Filing date

1998-07-13

Publication date

2001-05-14

1998-07-13 Application filed by Gs Dev Ab, Nobel Biocare Ab filed Critical Gs Dev Ab

1998-07-13 Priority to SE9802529A priority Critical patent/SE514908C2/sv

1998-07-13 Publication of SE9802529D0 publication Critical patent/SE9802529D0/xx

1999-07-06 Priority to US09/743,762 priority patent/US7004974B1/en

1999-07-06 Priority to AT99933447T priority patent/ATE353677T1/de

1999-07-06 Priority to AU49500/99A priority patent/AU4950099A/en

1999-07-06 Priority to EP99933447A priority patent/EP1094851B1/de

1999-07-06 Priority to PCT/SE1999/001231 priority patent/WO2000004940A1/en

1999-07-06 Priority to DE69935142T priority patent/DE69935142T2/de

2000-02-14 Publication of SE9802529L publication Critical patent/SE9802529L/xx

2001-05-14 Publication of SE514908C2 publication Critical patent/SE514908C2/sv

Links

210000000988 bone and bone Anatomy 0.000 title claims abstract description 84
239000008187 granular material Substances 0.000 claims abstract description 38
150000002632 lipids Chemical class 0.000 claims abstract description 35
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 32
238000002360 preparation method Methods 0.000 claims abstract description 30
239000007943 implant Substances 0.000 claims abstract description 29
239000001506 calcium phosphate Substances 0.000 claims abstract description 28
229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 26
235000011010 calcium phosphates Nutrition 0.000 claims abstract description 26
239000000203 mixture Substances 0.000 claims abstract description 20
229920001222 biopolymer Polymers 0.000 claims abstract description 8
238000010276 construction Methods 0.000 claims abstract description 7
241001465754 Metazoa Species 0.000 claims abstract description 3
150000003904 phospholipids Chemical class 0.000 claims description 19
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 18
239000003795 chemical substances by application Substances 0.000 claims description 17
229910052588 hydroxylapatite Inorganic materials 0.000 claims description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
239000011575 calcium Substances 0.000 claims description 9
239000003102 growth factor Substances 0.000 claims description 8
239000007788 liquid Substances 0.000 claims description 8
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 6
229920002674 hyaluronan Polymers 0.000 claims description 6
229960003160 hyaluronic acid Drugs 0.000 claims description 6
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
239000011734 sodium Substances 0.000 claims description 5
229910052708 sodium Inorganic materials 0.000 claims description 5
210000001124 body fluid Anatomy 0.000 claims description 4
239000010839 body fluid Substances 0.000 claims description 4
239000003814 drug Substances 0.000 claims description 4
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 3
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 3
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
102000002322 Egg Proteins Human genes 0.000 claims description 2
108010000912 Egg Proteins Proteins 0.000 claims description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
235000013345 egg yolk Nutrition 0.000 claims description 2
210000002969 egg yolk Anatomy 0.000 claims description 2
229910052731 fluorine Inorganic materials 0.000 claims description 2
239000011737 fluorine Substances 0.000 claims description 2
239000011777 magnesium Substances 0.000 claims description 2
229910052749 magnesium Inorganic materials 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
229940078499 tricalcium phosphate Drugs 0.000 claims description 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
239000008158 vegetable oil Substances 0.000 claims description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 12
RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 claims 2
229910019142 PO4 Inorganic materials 0.000 claims 1
150000005690 diesters Chemical class 0.000 claims 1
229910000392 octacalcium phosphate Inorganic materials 0.000 claims 1
YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 claims 1
230000008354 tissue degradation Effects 0.000 claims 1
150000005691 triesters Chemical class 0.000 claims 1
238000000034 method Methods 0.000 abstract description 10
230000007547 defect Effects 0.000 description 19
230000011164 ossification Effects 0.000 description 16
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 11
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 11
229940112869 bone morphogenetic protein Drugs 0.000 description 11
230000035876 healing Effects 0.000 description 11
210000004027 cell Anatomy 0.000 description 10
230000000694 effects Effects 0.000 description 10
239000002245 particle Substances 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
239000000969 carrier Substances 0.000 description 7
230000008569 process Effects 0.000 description 7
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
239000000919 ceramic Substances 0.000 description 6
239000000463 material Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 5
210000002805 bone matrix Anatomy 0.000 description 5
-1 calcium phosphate compound Chemical class 0.000 description 5
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
108010009583 Transforming Growth Factors Proteins 0.000 description 4
102000009618 Transforming Growth Factors Human genes 0.000 description 4
229910052791 calcium Inorganic materials 0.000 description 4
239000013078 crystal Substances 0.000 description 4
238000005553 drilling Methods 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000002502 liposome Substances 0.000 description 4
235000002639 sodium chloride Nutrition 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
229940122361 Bisphosphonate Drugs 0.000 description 3
208000006386 Bone Resorption Diseases 0.000 description 3
102000008186 Collagen Human genes 0.000 description 3
108010035532 Collagen Proteins 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
238000004873 anchoring Methods 0.000 description 3
150000004663 bisphosphonates Chemical class 0.000 description 3
210000002449 bone cell Anatomy 0.000 description 3
230000024279 bone resorption Effects 0.000 description 3
239000000316 bone substitute Substances 0.000 description 3
210000000845 cartilage Anatomy 0.000 description 3
229920001436 collagen Polymers 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
230000008439 repair process Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
150000003626 triacylglycerols Chemical class 0.000 description 3
208000004434 Calcinosis Diseases 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
241000404692 Opistognathidae Species 0.000 description 2
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
241000700159 Rattus Species 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
230000000975 bioactive effect Effects 0.000 description 2
230000002308 calcification Effects 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
239000004068 calcium phosphate ceramic Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000024245 cell differentiation Effects 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
239000004053 dental implant Substances 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
210000002744 extracellular matrix Anatomy 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
230000002962 histologic effect Effects 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
210000001847 jaw Anatomy 0.000 description 2
210000002414 leg Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000011707 mineral Substances 0.000 description 2
210000004877 mucosa Anatomy 0.000 description 2
210000000963 osteoblast Anatomy 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
239000000047 product Substances 0.000 description 2
239000002994 raw material Substances 0.000 description 2
238000011160 research Methods 0.000 description 2
238000004626 scanning electron microscopy Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
239000000758 substrate Substances 0.000 description 2
238000004627 transmission electron microscopy Methods 0.000 description 2
RLLPVAHGXHCWKJ-IEBWSBKVSA-N (3-phenoxyphenyl)methyl (1s,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-IEBWSBKVSA-N 0.000 description 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 description 1
206010065687 Bone loss Diseases 0.000 description 1
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
101100346656 Drosophila melanogaster strat gene Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
208000001393 Lathyrism Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
241000906034 Orthops Species 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
DRUQKRWRXOUEGS-NGERZBJRSA-N Samin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3O)=C1 DRUQKRWRXOUEGS-NGERZBJRSA-N 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
102000043168 TGF-beta family Human genes 0.000 description 1
108091085018 TGF-beta family Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
241001447056 Uristes Species 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
QZXMUPATKGLZAP-DXLAUQRQSA-N [(2S)-1-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QZXMUPATKGLZAP-DXLAUQRQSA-N 0.000 description 1
RBPWQIKZHBYIEY-PXCYNBOKSA-N [(2r)-2,3-bis[(z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC RBPWQIKZHBYIEY-PXCYNBOKSA-N 0.000 description 1
ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000009692 acute damage Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
229920001586 anionic polysaccharide Polymers 0.000 description 1
150000004836 anionic polysaccharides Chemical class 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
229910052586 apatite Inorganic materials 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
108010081355 beta 2-Microglobulin Proteins 0.000 description 1
102000015736 beta 2-Microglobulin Human genes 0.000 description 1
239000003462 bioceramic Substances 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
230000018678 bone mineralization Effects 0.000 description 1
230000010072 bone remodeling Effects 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000022159 cartilage development Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
239000004927 clay Substances 0.000 description 1
238000011281 clinical therapy Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
210000003298 dental enamel Anatomy 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000011363 dried mixture Substances 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000004821 effect on bone Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002745 epiphysis Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
210000004349 growth plate Anatomy 0.000 description 1
229940089982 healon Drugs 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
230000007941 heterotopic ossification Effects 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000009434 installation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000007794 irritation Effects 0.000 description 1
210000000629 knee joint Anatomy 0.000 description 1
210000001699 lower leg Anatomy 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000007726 management method Methods 0.000 description 1
210000002050 maxilla Anatomy 0.000 description 1
210000004086 maxillary sinus Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
244000309715 mini pig Species 0.000 description 1
FIJGNIAJTZSERN-DQQGJSMTSA-N monogalactosyl-diacylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O FIJGNIAJTZSERN-DQQGJSMTSA-N 0.000 description 1
229950006780 n-acetylglucosamine Drugs 0.000 description 1
210000003928 nasal cavity Anatomy 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000004819 osteoinduction Effects 0.000 description 1
230000000242 pagocytic effect Effects 0.000 description 1
230000003076 paracrine Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
230000003239 periodontal effect Effects 0.000 description 1
239000003186 pharmaceutical solution Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
229910000073 phosphorus hydride Inorganic materials 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
238000001350 scanning transmission electron microscopy Methods 0.000 description 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
229910052712 strontium Inorganic materials 0.000 description 1
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
229960001295 tocopherol Drugs 0.000 description 1
229930003799 tocopherol Natural products 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
239000011732 tocopherol Substances 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2803—Bones for mandibular reconstruction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools for implanting artificial joints
- A61F2/4601—Special tools for implanting artificial joints for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/3085—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with a threaded, e.g. self-tapping, bone-engaging surface, e.g. external surface
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Orthopedic Medicine & Surgery (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Chemistry (AREA)
Surgery (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Medical Informatics (AREA)
Composite Materials (AREA)
Materials Engineering (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)
Glass Compositions (AREA)

SE9802529A 1998-07-13 1998-07-13 Medel för benrekonstruktion SE514908C2 (sv)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
SE9802529A SE514908C2 (sv)	1998-07-13	1998-07-13	Medel för benrekonstruktion
US09/743,762 US7004974B1 (en)	1998-07-13	1999-07-06	Material for bone reconstruction
AT99933447T ATE353677T1 (de)	1998-07-13	1999-07-06	Material zur knochenrekonstruktion
AU49500/99A AU4950099A (en)	1998-07-13	1999-07-06	Material for bone reconstruction
EP99933447A EP1094851B1 (de)	1998-07-13	1999-07-06	Material zur knochenrekonstruktion
PCT/SE1999/001231 WO2000004940A1 (en)	1998-07-13	1999-07-06	Material for bone reconstruction
DE69935142T DE69935142T2 (de)	1998-07-13	1999-07-06	Material zur knochenrekonstruktion

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9802529A SE514908C2 (sv)	1998-07-13	1998-07-13	Medel för benrekonstruktion

Publications (3)

Publication Number	Publication Date
SE9802529D0 SE9802529D0 (sv)	1998-07-13
SE9802529L SE9802529L (sv)	2000-02-14
SE514908C2 true SE514908C2 (sv)	2001-05-14

Family

ID=20412076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9802529A SE514908C2 (sv)	1998-07-13	1998-07-13	Medel för benrekonstruktion

Country Status (7)

Country	Link
US (1)	US7004974B1 (de)
EP (1)	EP1094851B1 (de)
AT (1)	ATE353677T1 (de)
AU (1)	AU4950099A (de)
DE (1)	DE69935142T2 (de)
SE (1)	SE514908C2 (de)
WO (1)	WO2000004940A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2390794C (en) *	1999-12-03	2010-04-27	University Of Leeds	Fixation technology
US7771482B1 (en)	2000-05-09	2010-08-10	Ben-Zion Karmon	Method for tissue expansion and regeneration using bioresorbable inflatable devices
US20020114795A1 (en)	2000-12-22	2002-08-22	Thorne Kevin J.	Composition and process for bone growth and repair
JP2005528144A (ja)	2002-04-29	2005-09-22	バイオメットドイチュラントゲゼルシャフトミットベシュレンクテルハフトング	骨の組織工学用マトリックス（足場）としての構造複合体
AU2003279506A1 (en) *	2002-11-12	2004-06-03	Regenex Ltd.	Expandable devices and methods for tissue expansion, regenerationand fixation
FR2850282B1 (fr)	2003-01-27	2007-04-06	Jerome Asius	Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
US8012210B2 (en) *	2004-01-16	2011-09-06	Warsaw Orthopedic, Inc.	Implant frames for use with settable materials and related methods of use
US7473678B2 (en)	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US7799754B2 (en)	2004-10-14	2010-09-21	Biomimetic Therapeutics, Inc.	Compositions and methods for treating bone
US20100040668A1 (en) *	2006-01-12	2010-02-18	Rutgers, The State University Of New Jersey	Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US8287914B2 (en) *	2006-01-12	2012-10-16	Rutgers, The State University Of New Jersey	Biomimetic hydroxyapatite synthesis
US9034356B2 (en) *	2006-01-19	2015-05-19	Warsaw Orthopedic, Inc.	Porous osteoimplant
CA2637616A1 (en)	2006-01-19	2007-07-26	Osteotech, Inc.	Injectable and moldable bone substitute materials
ES2664229T3 (es)	2006-06-30	2018-04-18	Biomimetic Therapeutics, Llc	Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
JP5552315B2 (ja)	2006-11-03	2014-07-16	バイオミメティックセラピューティクス，エルエルシー	アースロデティック術のための組成物および方法
EP2014256A1 (de) *	2007-07-12	2009-01-14	Straumann Holding AG	Verbundmaterial zur Knochenreparatur
DE102007050440A1 (de) *	2007-10-18	2009-04-23	Alexakis, Antonis, Dr. med. dent.	Beschichtetes Granulat zur Neubildung von Knochenmaterial
US20090312841A1 (en) *	2008-06-13	2009-12-17	Zimmer, Inc.	Bone void filler
NZ602861A (en)	2008-09-09	2014-03-28	Biomimetic Therapeutics Llc	Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
US8277458B2 (en) *	2009-01-23	2012-10-02	Biomet Sports Medicine, Llc	Apparatus and method for arthroscopic transhumeral rotator cuff repair
US20100226956A1 (en)	2009-03-06	2010-09-09	Per Kjellin	Production of moldable bone substitute
DE102009020707A1 (de) *	2009-05-11	2010-11-25	Alexakis, Antonis, Dr. med. dent.	Beschichtetes Granulat zur Neubildung von Knochenmaterial
US8738144B2 (en) *	2009-05-12	2014-05-27	Ingenium, Llc	Bioelectric implant and method
WO2011017297A2 (en)	2009-08-03	2011-02-10	The University Of North Carolina At Chapel Hill	Biodegradable delivery system complexes for the delivery of bioactive compounds
CA2790403C (en)	2010-02-22	2019-08-27	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
US8551525B2 (en)	2010-12-23	2013-10-08	Biostructures, Llc	Bone graft materials and methods
DE102011119909A1 (de) *	2011-12-01	2013-06-06	Antonis Alexakis	Regenerations Hilfe für Knochendefekte
US10238507B2 (en)	2015-01-12	2019-03-26	Surgentec, Llc	Bone graft delivery system and method for using same
IL243401A (en)	2015-12-29	2017-12-31	Zion Karmon Ben	Instruments and methods for lifting Schneider membrane
IL248472A0 (en)	2016-10-13	2017-01-31	Zion Karmon Ben	Devices for tissue growth
CN108295305B (zh) *	2018-03-21	2021-09-28	苏州澳森匹科医疗科技股份有限公司	一种骨填充材料及其制备方法
US10687828B2 (en)	2018-04-13	2020-06-23	Surgentec, Llc	Bone graft delivery system and method for using same
US11116647B2 (en)	2018-04-13	2021-09-14	Surgentec, Llc	Bone graft delivery system and method for using same
US20210198312A1 (en) *	2019-12-31	2021-07-01	Helena Lovick	Growth factor concentrate and method of manufacture thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT352867B (de)	1976-05-12	1979-10-10	Battelle Institut E V	Knochenersatz-knochenverbund-oder prothesen- verankerungswerkstoff und verfahren zu seiner herstellung
FI78232C (fi)	1987-06-15	1989-07-10	Trident Oy	Implantat, som ersaetter en tand eller en del av benvaevnaden med syntetiskt material.
JP2631890B2 (ja) *	1988-10-22	1997-07-16	日本特殊陶業株式会社	持続型薬物含有セラミック体及びその使用方法
JPH0645487B2 (ja) *	1989-05-19	1994-06-15	徳山曹達株式会社	硬化材
DE69025378T2 (de) *	1989-10-20	1996-06-20	Bioapatite Ab	Implantatmaterialzusammensetzung, ihre Herstellung sowie ihre Verwendungen und daraus erhältliches Implantat
US5196201A (en) *	1989-10-20	1993-03-23	Bioapatite Ab	Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
SE464912B (sv) *	1989-10-25	1991-07-01	Bioapatite Ab	Implantationsmaterial foer aaterstaellning av benvaevnad samt saett foer dess tillverkning
DE69123312T2 (de)	1990-08-21	1997-03-20	Asahi Glass Co Ltd	Kalziumphosphat Glaskeramik
DE4120325A1 (de) *	1991-06-20	1992-12-24	Merck Patent Gmbh	Implantatwerkstoff
US5769897A (en)	1991-12-13	1998-06-23	Haerle; Anton	Synthetic bone
SE518578C2 (sv) *	1994-06-15	2002-10-29	Gs Dev Ab	Lipidbaserad komposition
US5660854A (en) *	1994-11-28	1997-08-26	Haynes; Duncan H	Drug releasing surgical implant or dressing material
CA2252860C (en)	1996-05-28	2011-03-22	1218122 Ontario Inc.	Resorbable implant biomaterial made of condensed calcium phosphate particles
WO1998030141A2 (en) *	1997-01-09	1998-07-16	Cohesion Technologies, Inc.	Devices for tissue repair and methods for preparation and use thereof
SE9802528D0 (sv)	1998-07-13	1998-07-13	Gs Dev Ab	Bone tissue restoring composition

1998
- 1998-07-13 SE SE9802529A patent/SE514908C2/sv not_active IP Right Cessation
1999
- 1999-07-06 AU AU49500/99A patent/AU4950099A/en not_active Abandoned
- 1999-07-06 WO PCT/SE1999/001231 patent/WO2000004940A1/en not_active Ceased
- 1999-07-06 EP EP99933447A patent/EP1094851B1/de not_active Expired - Lifetime
- 1999-07-06 US US09/743,762 patent/US7004974B1/en not_active Expired - Lifetime
- 1999-07-06 DE DE69935142T patent/DE69935142T2/de not_active Expired - Lifetime
- 1999-07-06 AT AT99933447T patent/ATE353677T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE353677T1 (de)	2007-03-15
DE69935142T2 (de)	2007-10-31
AU4950099A (en)	2000-02-14
DE69935142D1 (de)	2007-03-29
SE9802529L (sv)	2000-02-14
SE9802529D0 (sv)	1998-07-13
US7004974B1 (en)	2006-02-28
WO2000004940A1 (en)	2000-02-03
EP1094851A1 (de)	2001-05-02
EP1094851B1 (de)	2007-02-14

Legal Events

Date	Code	Title	Description
2018-08-28	NUG	Patent has lapsed

Publication	Publication Date	Title
US7004974B1 (en)	2006-02-28	Material for bone reconstruction
US8690874B2 (en)	2014-04-08	Composition and process for bone growth and repair
LeGeros	2002	Properties of osteoconductive biomaterials: calcium phosphates
Gu et al.	2013	Bone regeneration in rat calvarial defects implanted with fibrous scaffolds composed of a mixture of silicate and borate bioactive glasses
Wise	1995	Encyclopedic handbook of biomaterials and bioengineering: v. 1-2. Applications
US10751185B2 (en)	2020-08-25	Treatment of skeletal voids with implantable substrate hydrated with bone marrow concentrate
US5273964A (en)	1993-12-28	Inorganic and organic composition for treatment of bone lesions
Brandt et al.	2010	Nanocrystalline hydroxyapatite for bone repair: an animal study
Louisia et al.	1999	Coral grafting supplemented with bone marrow
US20100303888A1 (en)	2010-12-02	Composition for enhancing bone formation
SK144593A3 (en)	1994-07-06	Concave endoprosthesis with filling supportive for the growth of the bones
US20130095183A1 (en)	2013-04-18	Bone graft system
Liu et al.	2000	Bone healing in porous implants: a histological and histometrical comparative study on sheep
Rawlings	1993	Modern bone substitutes with emphasis on calcium phosphate ceramics and osteoinductors
LeGeros et al.	2008	Bioactive bioceramics
KR20210145130A (ko)	2021-12-01	프롤린-풍부 펩타이드를 포함하는 개선된 뼈 임플란트 매트릭스 및 그것의 제조 방법
Manassero et al.	2016	Coral scaffolds in bone tissue engineering and bone regeneration
Yilgor Huri et al.	2013	A biomimetic growth factor delivery strategy for enhanced regeneration of iliac crest defects
Camilli et al.	2004	Subperiosteal hydroxyapatite implants in rats submitted to ethanol ingestion
Maheshwari et al.	2023	Bicalcium phosphate as an asset in regenerative therapy
Daculsi et al.	2009	20 years of biphasic calcium phosphate bioceramics development and applications
Daculsi et al.	2008	Tricalcium phosphate/hydroxyapatite biphasic ceramics
Burstein	2000	Bone substitutes
Guillet et al.	2023	Bone formation beyond the skeletal envelope using calcium phosphate granules packed into a collagen pouch—A pilot study
US20090061002A1 (en)	2009-03-05	Calcium phospate based delivery of growth and differentiation factors to compromised bone